Clinical Trial

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

Name: ALTO-207 in Adults With Treatment-resistant Depression (TRD) — clinical trial record (NCT07553637)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.

Trial Details

NCT Number	NCT07553637
Lead Sponsor	Alto Neuroscience
Conditions	Treatment-resistant Depression (TRD)
Enrollment	178 participants
Start Date	2026-05
Primary Completion	2027-11 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-28